Drug class
Superparamagnetic iron-oxide nanoparticle MRI contrast agent; liver-specific reticuloendothelial contrast medium
Mechanism of action
Carboxydextran-coated superparamagnetic iron oxide nanoparticles are phagocytosed by Kupffer cells in the hepatic reticuloendothelial system. Their strong T2 and T2* relaxivity reduces signal intensity in normal liver parenchyma, increasing contrast between normal liver and lesions with reduced Kupffer-cell uptake.
General use cases
- Contrast enhancement for magnetic resonance imaging of focal liver lesions, particularly to improve lesion detection and characterisation in the liver, under product authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
